Update: Methicillin-Resistant Staphylococcus aureus Screening and Decolonization in Cardiac Surgery

Annals of Thoracic Surgery

Volumn 88, Issue 2, 2009, Pages 695-702

  Tom, Trisha S M ^a   Kruse, Michael W ^b   Reichman, Robert T ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Palomar Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFUROXIME; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; MINOCYCLINE; OXACILLIN; PLACEBO; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL TRIAL; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; DISINFECTION; DOSE CALCULATION; DRUG CONTRAINDICATION; HEALTH CARE PERSONNEL; HEART SURGERY; HOSPITAL INFECTION; HUMAN; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MEDIASTINITIS; MEDICAL TECHNOLOGIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NOSE SMEAR; OBESITY; PENICILLIN ALLERGY; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFECTION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SURGEON; SURGICAL RISK; THORAX SURGERY; THROAT CULTURE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; CEFAZOLIN; COST-BENEFIT ANALYSIS; HUMANS; MEDIASTINITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 67650744198     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.02.010     Document Type: Review

References (57)

1. Centers for Disease Control and Prevention. Methicillin resistant Staphylococcus aureus, 2007. http://www.cdc.gov/ncidod/dhqp/ar_mrsa.html Accessed June 2008
2. Harrington G., Russo P., Spelman D., et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 25 (2004) 472-476
3. Mekontso-Dessap A., Kirsch M., Brun-Buisson C., et al. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 32 (2001) 877-883
4. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations. Circulation 100 (1999) 1464-1480
5. Baum S.E., and Dooley D.P. Preventing methicillin-resistant Staphylococcus aureus infections in cardiovascular surgery patients: can we do any better?. Clin Infect Dis 38 (2004) 1561-1563
6. Carrier M., Marchand R., Auger P., et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg 123 (2002) 40-44
7. Davis K.A., Stewart J.J., Crouch H.K., Florez E., and Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39 (2004) 776-782
8. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197 (2008) 1226-1234
9. Dodds Ashley E.S., Carroll D.N., Engemann J.J., et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 38 (2004) 1555-1560
10. GovTrack.us. S. 2525-110th Congress: MRSA Infection Prevention and Patient Protection Act, 2007. http://www.govtrack.us/congress/bill.xpd?bill=s110-2525 Accessed June 2008
11. Centers for Medicare and Medicaid Services. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates, 2007. http://www.cms.hhs.gov/AcuteInpatientPPS/downloads/CMS-1533-FC.pdf 1-2140
12. Yokoe D.S., Mermel L.A., Anderson D.J., et al. A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals. Infect Control Hosp Epidemiol 29 Suppl (2008) S12-S21
13. BBL CHROMagar MRSA [package insert] (2006), BD Diagnostics, Sparks, MD
14. Spectra MRSA [package insert] (2008), Remel, Lenexa, KS
15. Jevaratnam D., Whitty C.J.M., Phillips K., et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomized crossover trial. BMJ 336 (2008) 927-930
16. BD Diagnostics. BD GeneOhm. http://www.bd.com/geneohm/english/products/idi_mrsa.asp Accessed October 2007
17. Cepheid. GeneXpert System. http://www.cepheid.com/tests-and-reagents/clinical-ivd-test/xpert-mrsa/ Accessed December 2008
18. Levenson D. The path to better MRSA control: how active surveillance and molecular tests can reduce infections and transmission. Clin Lab News 33 (2007) 1-7
19. Farley J.E., Stamper P.D., Ross T., Cai M., Speser S., and Carroll K.C. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. J Clin Microbiol 46 (2008) 743-746
20. Buehlmann M., Frei R., Fenner L., Dangel M., Fluckiger U., and Widmer A.F. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 29 (2008) 510-516
21. Mertz D., Frei R., Jaussi B., et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 45 (2007) 475-477
22. Marshall C., and Spelman D. Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit?. [Letter]. J Clin Microbiol 45 (2007) 3855
23. Datta R., and Huang S.S. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47 (2008) 176-181
24. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 (2007) 1763-1771
25. Marschall J., and Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 27 (2006) 1206-1212
26. Clancy M., Graepler A., Wilson M., Douglas I., Johnson J., and Price C.S. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 27 (2006) 1009-1017
27. Calfee D.P., Salgado C.D., Classen D., et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 29 Suppl (2008) S62-S80
28. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008) 409-418
29. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299 (2008) 1149-1157
30. San Juan R., Chaves F., Gude M.J.L., et al. Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventative approaches. J Thorac Cardiovasc Surg 134 (2007) 670-676
31. Jog S., Cunningham R., Cooper S., et al. Impact of preoperative screening for methicillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 69 (2008) 124-130
32. Dellinger E.P., Hausmann S.M., Bratzler D.W., et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 190 (2005) 9-15
33. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
34. Engelman R., Shahian D., Shemin R., et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 83 (2007) 1569-1576
35. CMS Office of Public Affairs website. Details for FY 2008 inpatient prospective payment system final rule. http://www.cms.hhs.gov/apps/media/press/factsheet.asp?Counter=2338 Accessed October 2008
36. Venditti M., Baiocchi P., Santini C., et al. Potential of clindamycin in addition to vancomycin for the treatment of oxacillin-resistant Staphylococcus aureus septicemia persisting under vancomycin therapy. Int J Antimicrob Agents 5 (1995) 123-128
37. Dellit T.H., Owens R.C., McGowan Jr. J.E., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44 (2007) 159-177
38. van Rijen M.M., Bonten M., Wenzel R.P., and Kluytmans J.A. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 61 (2008) 254-261
39. Trautmann M., Stecher J., Hemmer W., Luz K., and Panknin H.T. Intranasal mupirocin prophylaxis in elective surgery: a review of published studies. Chemotherapy 54 (2008) 9-16 Epub 2007 Dec 7
40. Milstone A.M., Passaretti C.L., and Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 46 (2008) 274-281
41. DeRiso II A.J., Ladowski J.S., Dillon T.A., Justice J.W., and Peterson A.C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109 (1996) 1556-1561
42. Segers P., Speekenbrink R.G., Ubbink D.T., van Ogtrop M.L., and de Mol B.A. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296 (2006) 2460-2466
43. Falagas M.E., Bliziotis I.A., and Fragoulis K.N. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 35 (2007) 106-114
44. Miller M.A., Dascal A., Portnoy J., and Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17 (1996) 811-813
45. Vali L., Davies S.E., Lai L.L., Dave J., and Amyes S.G. Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. J Antimicrob Chemother 61 (2008) 524-532
46. Raboud J., Saskin R., Simor A., et al. Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infect Control Hosp Epidemiol 26 (2005) 607-615
47. Kim T., Oh P.I., and Simor A.E. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 22 (2001) 99-104
48. West T.E., Guerry C., Hiott M., Morrow N., Ward K., and Salgado C.D. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 27 (2006) 233-238
49. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282 (1999) 1745-1751
50. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36 (2003) 592-598
51. Gavalda L., Masuet C., Beltran J., et al. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. Infect Control Hosp Epidemiol 27 (2006) 1264-1266
52. Sexton T., Clarke P., O'Neill E., et al. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 62 (2006) 187-194
53. Boyce J.M. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 65 (2007) 50-54
54. Wilson A.P., Hayman S., Whitehouse T., et al. Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study. Crit Care Med 35 (2007) 2275-2279
55. Albrich W.C., and Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infec Dis 8 (2008) 289-301
56. Cesur S., and Cokca F. Nasal carriage of methicillin-resistant Staphylococcus aureus among hospital staff and outpatients. Infect Control Hosp Epidemiol 25 (2004) 169-170
57. Blok H.E.M., Troelstra A., Kamp-Hopmans T.E.M., et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a dutch university hospital. Infect Control Hosp Epidemiol 24 (2003) 679-685